Analysis of the Correlation Between Helper T‐Lymphocyte Subsets and Atrial Fibrillation: An Observational and Mendelian Randomization Study
Cardiovascular Therapeutics · 2026-01 · 2026 (1)
DOI: 10.1155/cdr/4440768 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 04.08.2026. Verfasst von Jiahui Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China, sxmu.edu.cn. Hauptthemen laut MEDLINE: Atrial Fibrillation, T-Lymphocytes, Helper-Inducer, Polymorphism, Single Nucleotide. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Shanxi Health Commission.
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) is the predominant arrhythmia. Growing evidence indicates that immunological diseases may play a role in its development. This study combined observational and genetic analyses to investigate how T‐lymphocyte subsets and immunomodulatory drug targets influenced AF risk. Methods and Results This study retrospectively analyzed T lymphocyte subsets in 302 AF patients and 183 healthy controls. After balancing covariates via 1:1 propensity score matching, multivariate regression revealed AF patients had significantly higher absolute counts of Th1 and Th17 cells, and higher Th1/Th2 and Th17/Treg ratios ( p < 0.05). A subsequent two‐sample Mendelian randomization (MR) analysis, which assessed 731 immune traits and included drug‐target MR, established causal relationships. It showed that increased counts of CD4 + CD8dim T cells (OR = 1.03, p = 0.002) and IgD − CD38dim B cells (OR = 1.06, p = 0.0003) elevated AF risk. Furthermore, IL‐6R‐mediated CRP elevation increased AF risk (OR = 1.33, p = 5.18E‐7), whereas higher IL‐18 gene expression was protective (OR = 0.95, p = 0.036).
Conclusion
Immune dysfunction, especially T lymphocyte subsets, is a risk factor for the development of AF. The IL‐6R signaling pathway may be a potential target for AF prevention, whereas the use of IL‐18 inhibitors may increase the risk of AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China, sxmu.edu.cn.
- Graduate School, Shanxi Medical University, Taiyuan, China, sxmu.edu.cn.
- Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China, tsinghua.edu.cn.
- Department of Rheumatology Immunology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China, sxmu.edu.cn.
ORCID-Profile: Jiahui Li, Hongxuan Fan, Yalin Yuan, Bin Liang
Förderung
- Scientific Research Project of Shanxi Health Commission
Zitieren
APA
Li, J., Yang, Y., Fan, H., Huang, Z., Yuan, Y., Bai, R., Wang, X., & Liang, B. (2026). Analysis of the Correlation Between Helper T‐Lymphocyte Subsets and Atrial Fibrillation: An Observational and Mendelian Randomization Study. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/4440768
Vancouver
Li J, Yang Y, Fan H, Huang Z, Yuan Y, Bai R, et al. Analysis of the Correlation Between Helper T‐Lymphocyte Subsets and Atrial Fibrillation: An Observational and Mendelian Randomization Study. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/4440768
BibTeX
@article{Li2026,
author = {Li, Jiahui and Yang, Yafen and Fan, Hongxuan and Huang, Zhuolin and Yuan, Yalin and Bai, Rui and Wang, Xin and Liang, Bin},
title = {Analysis of the Correlation Between Helper T‐Lymphocyte Subsets and Atrial Fibrillation: An Observational and Mendelian Randomization Study},
journal = {Cardiovascular Therapeutics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cdr/4440768}
}
EUVIMED